SynthesisCNS drugs2016

Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis.

Diogo Mendes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.